reference/33869147

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33869147

Outgoing Links

Predicate	Object
contentType	Clinical Trial Protocol\|Journal Article\|Research Support, N.I.H., Extramural
endingPage	824
issn	1387-2877 1875-8908
issueIdentifier	2
pageRange	815-824
publicationName	Journal of Alzheimer's disease : JAD
startingPage	815
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ea81fc3f0392bafd116ec82dc008c978 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_558c6b02fc18b7ec0f11059366ed639d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2a3bc20b9cef8e17006ca8dca78aabdf
bibliographicCitation	Wharton W, Goldstein FC, Tansey MG, Brown AL, Tharwani SD, Verble DD, Cintron A, Kehoe PG. Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial. J Alzheimers Dis. 2018;61(2):815–24. PMID: 29254080; PMCID: PMC8933850.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38830538e11b4baa0f6f2905b98233f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86482bd9fd4673d2b512d711f8003b3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_104da47c6a1da4dfe1f5fd22e5beacc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9512214abc758fa0c9f0955d076b829 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a21ded828b724e1855e46c73ae468fb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8126622c6a0ec204724e05090422b450 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9523dd6b523fff690145873c975a0757 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_818fd30a2abc870d7c307bb75cb7cbc4
date	2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3233/jad-161198 https://pubmed.ncbi.nlm.nih.gov/29254080 https://pubmed.ncbi.nlm.nih.gov/PMC8933850
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1875-8908 https://portal.issn.org/resource/ISSN/1387-2877
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer’s (HEART) Trial
discusses	http://id.nlm.nih.gov/mesh/M0223750 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0024786
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000188 http://id.nlm.nih.gov/mesh/D000959Q000008 http://id.nlm.nih.gov/mesh/D016229Q000134 http://id.nlm.nih.gov/mesh/D000077333Q000008 http://id.nlm.nih.gov/mesh/D001921Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000503 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012084Q000187 http://id.nlm.nih.gov/mesh/D001741 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D017321 http://id.nlm.nih.gov/mesh/D015415Q000134 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016014 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D005845
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00559ea764f3549e2a9c714ecd8af73f

Total number of triples: 62.